Moleculin Biotech

MBRX · NASDAQ

$6.19+$5.93 (+2235.85%)TodayMarket closed · Oct 20, 7:43 PM ET

Prev close $0.265

Latest news

NewsSep 21, 9:41 AM ETAvi Kapoor
Dow Surges Over 200 Points; Chicago Fed Activity Index Falls In August
NewsSep 11, 5:06 PM ET
12 Health Care Stocks Moving In Friday's After-Market Session
Press releaseAug 14, 8:30 AM ETGlobe Newswire
Moleculin Biotech Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of Pivotal MIRACLE Trial
NewsAug 3, 5:05 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
NewsJul 31, 1:37 PM ETVandana Singh
Moleculin Biotech Stock Is Sinking Friday: What's Going On?
NewsJul 31, 1:05 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
Press releaseJul 31, 8:10 AM ETGlobe Newswire
Moleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients
NewsJul 31, 8:05 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsJul 29, 1:06 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsJun 30, 2:00 PM ETVandana Singh
Why is Moleculin Stock Falling Today?
NewsJun 23, 1:05 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsJun 23, 8:05 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsJun 4, 8:52 AM ET
Moleculin Biotech Enrolls 45th Participant In Its Pivotal Phase 2B/3 MIRACLE Study Of Annamycin In Combination With Cytarabine To Treat Relapsed Or Refractory Acute Myeloid Leukemia
Press releaseJun 4, 8:31 AM ETGlobe Newswire
Moleculin CEO, Walter Klemp, Highlights 45 Subject Enrollment Milestone in Recent Virtual Investor "What This Means" Segment
NewsMay 13, 12:41 PM ETVandana Singh
Nano-Cap Moleculin Biotech Approaches Key Leukemia Trial Data Unblinding
Press releaseMay 13, 8:00 AM ETGlobe Newswire
Moleculin Announces Imminent MIRACLE Trial Unblinding as Blinded Data Continue to Significantly Outperform Historical Benchmarks
Press releaseApr 7, 8:36 AM ETGlobe Newswire
Moleculin Releases Next CEO Corner Segment Highlighting Annamycin's Non-Cardiotoxic Profile
Press releaseMar 27, 9:15 AM ETPRNewswire
Scalable Biotech Manufacturing Unlocks a $14B Market
Press releaseMar 23, 8:31 AM ETGlobe Newswire
Moleculin Hits 45 Subject Enrollment Milestone, Triggering Final Countdown to Mid-2026 MIRACLE Trial Data Readout
Press releaseMar 19, 8:36 AM ETGlobe Newswire
Moleculin Reports Full Year 2025 Financial Results and Confirms Highly Anticipated 45-Patient Interim Data Unblinding in Pivotal MIRACLE Trial On Track for Mid-2026
Press releaseMar 11, 9:00 AM ETGlobe Newswire
Moleculin Releases Next CEO Corner Segment Highlighting MIRACLE Study
NewsFeb 19, 2:07 PM ETAvi Kapoor
Crude Oil Gains 2%; Walmart Posts Upbeat Earnings
NewsFeb 19, 12:05 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsFeb 19, 9:45 AM ETAvi Kapoor
Dow Falls Over 250 Points; US Initial Jobless Claims Decline
Press releaseFeb 18, 8:20 AM ETGlobe Newswire
Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)
Press releaseFeb 17, 8:35 AM ETGlobe Newswire
Moleculin Announces Notice of Allowance for Japanese Patent Covering Annamycin
NewsOct 22, 5:06 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
Press releaseOct 21, 9:20 AM ETPRNewswire
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
NewsAug 28, 1:06 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsAug 28, 12:54 PM ETAvi Kapoor
Nasdaq Surges 100 Points; Dollar General Earnings Beat Views
NewsAug 28, 10:27 AM ETAvi Kapoor
US Stocks Mixed; Nvidia Posts Upbeat Earnings
NewsJul 31, 5:07 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
NewsJul 29, 5:06 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
NewsJul 29, 1:06 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsJun 20, 1:36 PM ETAvi Kapoor
Gold Moves Lower; Darden Restaurants Earnings Top Views
NewsJun 20, 10:14 AM ETAvi Kapoor
Dow Surges Over 100 Points; Accenture Posts Upbeat Earnings
NewsJun 4, 1:08 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
Press releaseMar 11, 8:45 AM ETPRNewswire
Moleculin Biotech, Inc. Participates in the Virtual Investor "Top 5 for '25" On-Demand Conference
Press releaseMar 10, 8:45 AM ETPRNewswire
Moleculin to Present at the 37th Annual ROTH Conference
Press releaseMar 6, 8:30 AM ETPRNewswire
Moleculin Announces Additional Annamycin Patent Allowances to Enhance Global Exclusivity
Press releaseMar 3, 8:30 AM ETPRNewswire
Moleculin Abstract Accepted for Poster Presentation at the Acute Leukemias XIX (ISALXIX) International Symposium
Press releaseFeb 25, 12:35 PM ETPRNewswire
Moleculin Announces Pricing of $3.5 Million Registered Direct Offering and Concurrent Private Placement Priced At The Market Under Nasdaq Rules
NewsFeb 14, 4:05 PM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsFeb 14, 6:05 AM ETRishabh Mishra
US Stocks Set For A Volatile Start: Analyst Dismisses Chances Of 20%+ S&P 500 Gain For Third Year In A Row, But Says 'Investors Should Be Optimistic'

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Dow Surges Over 200 Points; Chicago Fed Activity Index Falls In August

12 Health Care Stocks Moving In Friday's After-Market Session

Moleculin Biotech Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of Pivotal MIRACLE Trial

12 Health Care Stocks Moving In Monday's After-Market Session

Moleculin Biotech Stock Is Sinking Friday: What's Going On?

12 Health Care Stocks Moving In Friday's Intraday Session

Moleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

Why is Moleculin Stock Falling Today?

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Moleculin Biotech Enrolls 45th Participant In Its Pivotal Phase 2B/3 MIRACLE Study Of Annamycin In Combination With Cytarabine To Treat Relapsed Or Refractory Acute Myeloid Leukemia

Moleculin CEO, Walter Klemp, Highlights 45 Subject Enrollment Milestone in Recent Virtual Investor "What This Means" Segment

Nano-Cap Moleculin Biotech Approaches Key Leukemia Trial Data Unblinding

Moleculin Announces Imminent MIRACLE Trial Unblinding as Blinded Data Continue to Significantly Outperform Historical Benchmarks

Moleculin Releases Next CEO Corner Segment Highlighting Annamycin's Non-Cardiotoxic Profile

Scalable Biotech Manufacturing Unlocks a $14B Market

Moleculin Hits 45 Subject Enrollment Milestone, Triggering Final Countdown to Mid-2026 MIRACLE Trial Data Readout

Moleculin Reports Full Year 2025 Financial Results and Confirms Highly Anticipated 45-Patient Interim Data Unblinding in Pivotal MIRACLE Trial On Track for Mid-2026

Moleculin Releases Next CEO Corner Segment Highlighting MIRACLE Study

Crude Oil Gains 2%; Walmart Posts Upbeat Earnings

12 Health Care Stocks Moving In Thursday's Intraday Session

Dow Falls Over 250 Points; US Initial Jobless Claims Decline

Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)

Moleculin Announces Notice of Allowance for Japanese Patent Covering Annamycin

12 Health Care Stocks Moving In Wednesday's After-Market Session

Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions

12 Health Care Stocks Moving In Thursday's Intraday Session

Nasdaq Surges 100 Points; Dollar General Earnings Beat Views

US Stocks Mixed; Nvidia Posts Upbeat Earnings

12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gold Moves Lower; Darden Restaurants Earnings Top Views

Dow Surges Over 100 Points; Accenture Posts Upbeat Earnings

12 Health Care Stocks Moving In Wednesday's Intraday Session

Moleculin Biotech, Inc. Participates in the Virtual Investor "Top 5 for '25" On-Demand Conference

Moleculin to Present at the 37th Annual ROTH Conference

Moleculin Announces Additional Annamycin Patent Allowances to Enhance Global Exclusivity

Moleculin Abstract Accepted for Poster Presentation at the Acute Leukemias XIX (ISALXIX) International Symposium

Moleculin Announces Pricing of $3.5 Million Registered Direct Offering and Concurrent Private Placement Priced At The Market Under Nasdaq Rules

12 Health Care Stocks Moving In Friday's Pre-Market Session

US Stocks Set For A Volatile Start: Analyst Dismisses Chances Of 20%+ S&P 500 Gain For Third Year In A Row, But Says 'Investors Should Be Optimistic'